We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Urinary Dipstick Tested for Intestinal Schistosomiasis

By LabMedica International staff writers
Posted on 18 Mar 2013
Print article
Image: A schistosome pair, with the thin female located in the male gynecophorical canal (Photo courtesy of MetaPathogen).
Image: A schistosome pair, with the thin female located in the male gynecophorical canal (Photo courtesy of MetaPathogen).
The Urine Circulating Cathodic Antigen (CCA) dipstick has been tested as a substitute for microscopy for mapping and point-of-care (POC) diagnosis of intestinal schistosomiasis.

The diagnostic performance of a commercially available urinary CCA dipstick test has been compared to that of fecal microscopy for POC diagnosis in preschool-aged children.

Scientists at the Liverpool School of Tropical Medicine (Liverpool, UK) working with colleagues in Uganda recruited a total of 925 children whose mean age was 2.8 years, from six lakeshore villages representative of high, moderate and low levels of disease transmission. At baseline, all children were tested for intestinal schistosomiasis by microscopic examination of duplicate Kato-Katz smears prepared from a single stool; by antigen detection with the urine CCA immunochromatographic dipstick; and by serology with a commercially available enzyme-linked immunosorbent assay (ELISA; IVD Inc.; Carlsbad, CA, USA) that measures host antibody titers to soluble egg antigens.

In low, moderate, and high transmission settings, the observed prevalence of egg-patent schistosomiasis according to fecal microscopy was 7.2%, 16.9% and 38.8% before treatment, and 6.9%, 25.0% and 47.5% one year after treatment. In low, moderate, and high transmission settings, the observed prevalence of Schistosoma mansoni infections according to CCA dipsticks (Rapid Medical Diagnostics; Pretoria, Republic of South Africa) was 45.9%, 45.4% and 56.1% before treatment, and 39.6%, 44.8% and 55.9% one year after treatment, respectively. Most of the positive diagnoses were single positive reactions, with few double and triple positive reaction recorded.

According to the ELISA results, the observed prevalence of S. mansoni infections was 36.0%, 49.0%, and 81.6% before treatment and 18.4%, 52.8%, and 92.0% one year after treatment, in low, moderate, and high transmission settings, respectively. As a point-of-care diagnosis, the urine CCA dipstick achieved sensitivity values ranging from 52.5% to 63.2% and specificity values of 57.7% to 75.6%. Fecal microscopy achieved very high specificities of greater than 87%, but sensitivities as low as 16.7% in the low transmission setting.

The authors concluded that the CCA is a viable alternative for diagnosis of S. mansoni infections in preschool-aged children, particularly in low transmission settings or in areas where treatment has reduced prevalence to low levels. The urine CCA commercial test was proven more sensitive than fecal smears for mapping proposes, and it was as reliable as fecal microscopy for point-of-care diagnosis. The study was published on January 24, 2013, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
Liverpool School of Tropical Medicine
IVD Inc.
Rapid Medical Diagnostics

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.